- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak and Imation keep quiet on rumors
Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of
Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of Imation, such as the company's medical imaging business, which includes dry printers, x-ray film, and PACS operations.
Speculation about a possible deal has surfaced on online investment boards and was rife on the exhibit floor at last month's American Healthcare Radiology Administrator's meeting in Las Vegas. Representatives from both Kodak and Imation said that as a matter of corporate policy the companies do not comment on rumors.
If Kodak did buy Imation's medical imaging business, the deal would give Kodak an even stronger position in the x-ray film and PACS markets. Rumors about Kodak have proven wrong in the past, however. Speculation late last year that Kodak would sell its medical imaging business to Johnson & Johnson proved to be untrue (SCAN 1/21/98).
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
